Endpoint definition
↥| Name | G6_MYASTHENIA_ADVERSE |
|---|---|
| Long name | Myasthenia gravis, drug-induced |
| Hospital Discharge: ATC drug used | ANY |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 31 | 22 | 9 |
| Unadjusted prevalence (%) | 0.01 | 0.02 | 0.01 |
| Mean age at first event (years) | 46.60 | 40.52 | 61.48 |
| Case fatality at 5-years (%) | 0.00 | 0.00 | 0.00 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | 2.0 |
| Recurrence at 6 months (%) | 45.16 | 45.45 | 44.44 |
Survival analyses between endpoints
↥Plot
before Myasthenia gravis, drug-induced
after Myasthenia gravis, drug-induced
Loading survival analyses plot…
Table
Loading survival analyses table…